PA
AXSM icon

Profund Advisors’s Axsome Therapeutics AXSM Stock Holding History

Profund Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371K Sell
2,194
-274
-11% -$47.3K 0.01% 653
2025
Q4 		$451K Sell
2,468
-654
-21% -$91.3K 0.01% 607
2025
Q3 		$379K Sell
3,122
-941
-23% -$106K 0.01% 631
2025
Q2 		$424K Buy
4,063
+180
+5% +$19.1K 0.02% 523
2025
Q1 		$453K Sell
3,883
-1,003
-21% -$114K 0.02% 505
2024
Q4 		$413K Sell
4,886
-730
-13% -$67.1K 0.02% 606
2024
Q3 		$505K Sell
5,616
-1,255
-18% -$110K 0.02% 526
2024
Q2 		$553K Sell
6,871
-2,144
-24% -$159K 0.02% 472
2024
Q1 		$719K Buy
9,015
+701
+8% +$58.8K 0.03% 453
2023
Q4 		$662K Buy
8,314
+181
+2% +$12.1K 0.03% 432
2023
Q3 		$568K Sell
8,133
-711
-8% -$53.1K 0.03% 432
2023
Q2 		$636K Sell
8,844
-1,681
-16% -$124K 0.03% 431
2023
Q1 		$649K Buy
10,525
+7,416
+239% +$487K 0.04% 423
2022
Q4 		$240K Buy
+3,109
New +$186K 0.02% 778
2020
Q3 		– Sell
-2,464
Closed -$203K – 972
2020
Q2 		$203K Buy
+2,464
New +$190K 0.01% 821
2020
Q1 		– Sell
-2,680
Closed -$277K – 812
2019
Q4 		$277K Buy
+2,680
New +$108K 0.01% 974

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Profund Advisors's AXSM Position: Q1 2026 in Review

Profund Advisors reduced its Axsome Therapeutics (AXSM) stake by 11% in Q1 2026, selling an estimated $47.3K and leaving 2,194 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #653.

Profund Advisors first reported a position in AXSM in Q4 2019 and has held it in 16 quarters since. The position peaked at $719K in Q1 2024. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Profund Advisors held 2,194 shares of Axsome Therapeutics worth $371K as of Q1 2026.
  • Profund Advisors sold 274 Axsome Therapeutics shares in Q1 2026, an estimated $47.3K.
  • Axsome Therapeutics made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #653 holding.
  • Profund Advisors first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • Profund Advisors's Axsome Therapeutics position peaked at $719K in Q1 2024.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.